Pilot Study Of The Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1 In Patients Taking Highly Active Antiretroviral Therapy.
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2014
At a glance
- Drugs Antiretrovirals; Raltegravir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 07 Dec 2011 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 07 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2011 Planned End Date changed from 1 Feb 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.